In addition, several MAPK inhibitors increase PDT-induced cytotoxicity in a human squamous carcinoma cell line [139], as does the inhibition of nuclear factor erythroid 2-related factor 2 (NRF2) with an NRF2 inhibitor [140]. The gene discussed is NFE2L2; the disease is squamous cell carcinoma.